Point72 Hong Kong’s Eli Lilly LLY Stock Holding History

Point72 Hong Kong’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,600	Closed	-$2.13M	–	969
2022 Q3	$2.13M	Buy	6,600 +4,900	+288%	+$1.55M	0.07%	332
2022 Q2	$551K	Sell	1,700 -1,100	-39%	-$330K	0.02%	688
2022 Q1	$802K	Sell	2,800 -700	-20%	-$180K	0.03%	581
2021 Q4	$967K	Sell	3,500 -5,900	-63%	-$1.5M	0.03%	562
2021 Q3	$2.17M	Sell	9,400 -10,900	-54%	-$2.69M	0.07%	425
2021 Q2	$4.66M	Buy	20,300 +500	+3%	+$100K	0.15%	139
2021 Q1	$3.7M	Buy	19,800 +5,800	+41%	+$1.13M	0.12%	198
2020 Q4	$2.36M	Buy	+14,000	New	+$2.09M	0.11%	230

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Point72 Hong Kong's LLY Position: Q3 2025 in Review

Point72 Hong Kong increased its Eli Lilly (LLY) stake by 17% in Q3 2025, buying an estimated $642K and bringing the position to 5,866 shares worth $4.48M. The position accounts for 0.21% of the portfolio, ranked #90.

Point72 Hong Kong first reported a position in LLY in Q3 2014 and has held it in 25 quarters since. The position peaked at $23M in Q3 2024. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

Point72 Hong Kong held 5,866 shares of Eli Lilly worth $4.48M as of Q3 2025.
Point72 Hong Kong bought 863 Eli Lilly shares in Q3 2025, an estimated $642K.
Eli Lilly made up 0.21% of Point72 Hong Kong's portfolio in Q3 2025, its #90 holding.
Point72 Hong Kong first reported a position in Eli Lilly in Q3 2014 and has held it in 25 quarters since.
Point72 Hong Kong's Eli Lilly position peaked at $23M in Q3 2024.
3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.